Global Blood Safety Resources

Displaying 20 of 39 results

Sort by:

Workshop

01 Jul 2020

Case Study: Achieving 100% voluntary nonremunerated blood donation

This is a case study prepared by the Global Blood Safety Working Party sharing experience from the Sultanate of Oman.

Case Study

23 Sep 2021

Domestic scalable plasma processing: technological approaches and solutions for LMIC, Josephine Cheng

This is the powerpoint presentation file of Josephine Cheng from Day 3 Session 1 Scale-up for domestic processing of plasma: technology options, equipment and oversight.

Presentation

18 Sep 2022

Donor Availability in the Low Resource Environment: How Can we Deal with the Challenges?

Scientific Publication

20 Aug 2020

Eléments à prendre en compte dans la préparation et la transfusion du plasma de personnes guéries du COVID-19 dans les pays à faibles ou moyens revenus

Scientific Publication

26 Jun 2024

Generating pathways to domestically sourced plasma-derived medicinal products: Report from a workshop by the International Plasma and Fractionation Association and the WP on Global Blood Safety

Albert Farrugia, Robert Perry, Françoise Rossi, Leni von Bonsdorff, Glynis Bowie, Jean-Claude Faber, Jeh-Han Omarjee, Jay Epstein, Jenny White

Scientific Publication

05 Dec 2023

Guidance to identify barriers in blood services using the blood system self-assessment (BSS) Tool

WHO publication

Guideline

03 Oct 2022

ICSPP LAUNCH - English

Recommendation

03 Oct 2022

ICSPP LAUNCH - Español

Recommendation

03 Oct 2022

ICSPP LAUNCH - Français

Recommendation

03 Oct 2022

ICSPP LAUNCH - Italiano

Recommendation

10 Jun 2019

Improving haemophilia therapy in developing countries: virus-safe cryoprecipitate

Scientific Publication

21 Sep 2021

Key steps to improve quality of plasma for further processing, Vee Armstrong

This is the powerpoint presentation file of Vee Armstrong from Day 1 Session 2 Options for fractionation of domestic plasma.

Presentation

22 Sep 2021

Mini-pool solvent/detergent of plasma, cryoprecipitate & caprylic acid fractionation of immunoglobulins (VIPS), Magdy El-Ekiaby

This is the powerpoint presentation file of Magdy El-Ekiaby from Day 2 Session 1 Options to improve the access to safe plasma protein products in LMIC.

Presentation

23 Sep 2021

Models for technology transfer and technical assistance, Leni von Bonsdorff

This is the powerpoint presentation file of Leni von Bonsdorff from Day 3 Session 2 The Way Forward.

Presentation

21 Sep 2021

Oversight of contract plasma fractionation, Françoise Rossi

This is the powerpoint presentation file of Françoise Rossi from Day 1 Session 2 Options for fractionation of domestic plasma.

Presentation

22 Sep 2021

Pathogen reduction of COVID-19 convalescent plasma, Salwa Hindawi

This is the powerpoint presentation file of Salwa Hindawi from Day 2 Session 1 Options to improve the access to safe plasma protein products in LMIC.

Presentation

31 Dec 2019

Plasma fractionation in countries with limited infrastructure and low-/medium income: How to move forward?

Scientific Publication

23 Sep 2021

Plasma fractionation of animal-derived immunoglobulins in LMIC: lessons to be learned for human plasma IgG production, Mariángela Vargas

This is the powerpoint presentation file of Mariángela Vargas from Day 3 Session 1 Scale-up for domestic processing of plasma: technology options, equipment and oversight.

Presentation

21 Sep 2021

Plasma fractionation technologies: benefits and limitations; technical issues, Jan Bult

This is the powerpoint presentation file of Jan Bult from Day 1 Session 2 Options for fractionation of domestic plasma.

Presentation

03 Nov 2020

Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections

Scientific Publication

Global Blood Safety Resources

Workshop

Workshop Stepwise Access to Safe Plasma Proteins in Resource-Constrained Countries

Case Study: Achieving 100% voluntary nonremunerated blood donation

Domestic scalable plasma processing: technological approaches and solutions for LMIC, Josephine Cheng

Donor Availability in the Low Resource Environment: How Can we Deal with the Challenges?

Eléments à prendre en compte dans la préparation et la transfusion du plasma de personnes guéries du COVID-19 dans les pays à faibles ou moyens revenus

Generating pathways to domestically sourced plasma-derived medicinal products: Report from a workshop by the International Plasma and Fractionation Association and the WP on Global Blood Safety

Guidance to identify barriers in blood services using the blood system self-assessment (BSS) Tool

ICSPP LAUNCH - English

ICSPP LAUNCH - Español

ICSPP LAUNCH - Français

ICSPP LAUNCH - Italiano

Improving haemophilia therapy in developing countries: virus-safe cryoprecipitate

Key steps to improve quality of plasma for further processing, Vee Armstrong

Mini-pool solvent/detergent of plasma, cryoprecipitate & caprylic acid fractionation of immunoglobulins (VIPS), Magdy El-Ekiaby

Models for technology transfer and technical assistance, Leni von Bonsdorff

Oversight of contract plasma fractionation, Françoise Rossi

Pathogen reduction of COVID-19 convalescent plasma, Salwa Hindawi

Plasma fractionation in countries with limited infrastructure and low-/medium income: How to move forward?

Plasma fractionation of animal-derived immunoglobulins in LMIC: lessons to be learned for human plasma IgG production, Mariángela Vargas

Plasma fractionation technologies: benefits and limitations; technical issues, Jan Bult

Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections

Registration for ISBT Milan 2025 is now open! 📢

Global Blood Safety Resources

Workshop

Our Corporate Partners

Register for our newsletter

Registration for ISBT Milan 2025 is now open! 📢